Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2023-02-21 17:14:53 UTC |
---|
HMDB ID | HMDB0000510 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Aminoadipic acid |
---|
Description | Aminoadipic acid (CAS: 542-32-5), also known as 2-aminoadipate, is a metabolite in the principal biochemical pathway of lysine. It is an intermediate in the metabolism (i.e. breakdown or degradation) of lysine and saccharopine. It antagonizes neuroexcitatory activity modulated by the glutamate receptor N-methyl-D-aspartate (NMDA). Aminoadipic acid has also been shown to inhibit the production of kynurenic acid, a broad spectrum excitatory amino acid receptor antagonist, in brain tissue slices (PMID: 8566117 ). Recent studies have shown that aminoadipic acid is elevated in prostate biopsy tissues from prostate cancer patients (PMID: 23737455 ). Mutations in DHTKD1 (dehydrogenase E1 and transketolase domain-containing protein 1) have been shown to cause human 2-aminoadipic aciduria and 2-oxoadipic aciduria via impaired decarboxylation of 2-oxoadipate to glutaryl-CoA, which is the last step in the lysine degradation pathway (PMID: 23141293 ). Aging, diabetes, sepsis, and renal failure are known to catalyze the oxidation of lysyl residues to form 2-aminoadipic acid in human skin collagen and potentially other tissues (PMID: 18448817 ). Proteolytic breakdown of these tissues can lead to the release of free 2-aminoadipic acid. Studies in rats indicate that aminoadipic acid (along with the three branched-chain amino acids: leucine, valine, and isoleucine) levels are elevated in the pre-diabetic phase and so aminoadipic acid may serve as a predictive biomarker for the development of diabetes (PMID: 15389298 ). Long-term hyperglycemia of endothelial cells can also lead to elevated levels of aminoadipate which is thought to be a sign of lysine breakdown through oxidative stress and reactive oxygen species (ROS) (PMID: 21961526 ). 2-Aminoadipate is a potential small-molecule marker of oxidative stress (PMID: 21647514 ). Therefore, depending on the circumstances aminoadipic acid can act as an acidogen, a diabetogen, an atherogen, and a metabotoxin. An acidogen is an acidic compound that induces acidosis, which has multiple adverse effects on many organ systems. A diabetogen is a compound that can lead to type 2 diabetes. An atherogen is a compound that leads to atherosclerosis and cardiovascular disease. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of aminoadipic acid are associated with at least two inborn errors of metabolism including 2-aminoadipic aciduria and 2-oxoadipic aciduria. Aminoadipic acid is an organic acid and abnormally high levels of organic acids in the blood (organic acidemia), urine (organic aciduria), the brain, and other tissues lead to general metabolic acidosis. Acidosis typically occurs when arterial pH falls below 7.35. In infants with acidosis, the initial symptoms include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). These can progress to heart abnormalities, kidney abnormalities, liver damage, seizures, coma, and possibly death. These are also the characteristic symptoms of the untreated IEMs mentioned above. Many affected children with organic acidemias experience intellectual disability or delayed development. In adults, acidosis or acidemia is characterized by headaches, confusion, feeling tired, tremors, sleepiness, and seizures. As a diabetogen, serum aminoadipic levels appear to regulate glucose homeostasis and have been highly predictive of individuals who later develop diabetes (PMID: 24091325 ). In particular, aminoadipic acid lowers fasting plasma glucose levels and enhances insulin secretion from human islets. As an atherogen, aminoadipic acid has been found to be produced at high levels via protein lysine oxidation in atherosclerotic plaques (PMID: 28069522 ). |
---|
Structure | InChI=1S/C6H11NO4/c7-4(6(10)11)2-1-3-5(8)9/h4H,1-3,7H2,(H,8,9)(H,10,11)/t4-/m0/s1 |
---|
Synonyms | Value | Source |
---|
(S)-2-Aminohexanedioic acid | ChEBI | L-2-Aminoadipate | ChEBI | L-2-Aminohexanedioate | ChEBI | L-alpha-Aminoadipate | ChEBI | L-alpha-Aminoadipic acid | ChEBI | L-2-Aminoadipic acid | Kegg | (S)-2-Aminohexanedioate | Generator | L-2-Aminohexanedioic acid | Generator | L-a-Aminoadipate | Generator | L-a-Aminoadipic acid | Generator | L-Α-aminoadipate | Generator | L-Α-aminoadipic acid | Generator | Aminoadipate | Generator | (2S)-2-Aminohexanedioic acid | HMDB | (2S)-2-Azaniumyl-6-hydroxy-6-oxohexanoate | HMDB | (S)-2-Aminoadipic acid | HMDB | 2-Aminoadipate | HMDB | 2-Aminoadipic acid | HMDB | 2-Aminohexanedioic acid | HMDB | L-Aminoadipic acid | HMDB | alpha-Aminoadipic acid | HMDB | Α-aminoadipic acid | HMDB |
|
---|
Chemical Formula | C6H11NO4 |
---|
Average Molecular Weight | 161.1558 |
---|
Monoisotopic Molecular Weight | 161.068807845 |
---|
IUPAC Name | (2S)-2-aminohexanedioic acid |
---|
Traditional Name | aminoadipate |
---|
CAS Registry Number | 1118-90-7 |
---|
SMILES | N[C@@H](CCCC(O)=O)C(O)=O |
---|
InChI Identifier | InChI=1S/C6H11NO4/c7-4(6(10)11)2-1-3-5(8)9/h4H,1-3,7H2,(H,8,9)(H,10,11)/t4-/m0/s1 |
---|
InChI Key | OYIFNHCXNCRBQI-BYPYZUCNSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | L-alpha-amino acids |
---|
Alternative Parents | |
---|
Substituents | - L-alpha-amino acid
- Medium-chain fatty acid
- Amino fatty acid
- Dicarboxylic acid or derivatives
- Fatty acid
- Fatty acyl
- Amino acid
- Carboxylic acid
- Organopnictogen compound
- Organic nitrogen compound
- Amine
- Organic oxygen compound
- Primary amine
- Organooxygen compound
- Organonitrogen compound
- Primary aliphatic amine
- Carbonyl group
- Hydrocarbon derivative
- Organic oxide
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | Biological locationRoute of exposureSourceEndogenousExogenousFood- Food (HMDB: HMDB0000510)
VegetableCereal and cereal productGourdHerb and spiceMilk and milk productUnfermented milk- Milk (Cow) (FooDB: FOOD00618)
- Cow milk, pasteurized, vitamin A + D added, 0% fat (FooDB: FOOD00889)
- Cow milk, pasteurized, vitamin A + D added, 1% fat (FooDB: FOOD00890)
- Cow milk, pasteurized, vitamin A + D added, 2% fat (FooDB: FOOD00891)
- Cow milk, pasteurized, vitamin D added, 3.25% fat (FooDB: FOOD00892)
Pulse
|
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 196 - 198 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 2.2 mg/mL | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Aminoadipic acid,1TMS,isomer #1 | C[Si](C)(C)OC(=O)CCC[C@H](N)C(=O)O | 1613.1 | Semi standard non polar | 33892256 | Aminoadipic acid,1TMS,isomer #2 | C[Si](C)(C)OC(=O)[C@@H](N)CCCC(=O)O | 1567.0 | Semi standard non polar | 33892256 | Aminoadipic acid,1TMS,isomer #3 | C[Si](C)(C)N[C@@H](CCCC(=O)O)C(=O)O | 1630.7 | Semi standard non polar | 33892256 | Aminoadipic acid,2TMS,isomer #1 | C[Si](C)(C)OC(=O)CCC[C@H](N)C(=O)O[Si](C)(C)C | 1619.8 | Semi standard non polar | 33892256 | Aminoadipic acid,2TMS,isomer #2 | C[Si](C)(C)N[C@@H](CCCC(=O)O[Si](C)(C)C)C(=O)O | 1706.9 | Semi standard non polar | 33892256 | Aminoadipic acid,2TMS,isomer #3 | C[Si](C)(C)N[C@@H](CCCC(=O)O)C(=O)O[Si](C)(C)C | 1676.2 | Semi standard non polar | 33892256 | Aminoadipic acid,2TMS,isomer #4 | C[Si](C)(C)N([C@@H](CCCC(=O)O)C(=O)O)[Si](C)(C)C | 1829.2 | Semi standard non polar | 33892256 | Aminoadipic acid,3TMS,isomer #1 | C[Si](C)(C)N[C@@H](CCCC(=O)O[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1723.0 | Semi standard non polar | 33892256 | Aminoadipic acid,3TMS,isomer #1 | C[Si](C)(C)N[C@@H](CCCC(=O)O[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1763.3 | Standard non polar | 33892256 | Aminoadipic acid,3TMS,isomer #1 | C[Si](C)(C)N[C@@H](CCCC(=O)O[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1896.1 | Standard polar | 33892256 | Aminoadipic acid,3TMS,isomer #2 | C[Si](C)(C)OC(=O)CCC[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1874.8 | Semi standard non polar | 33892256 | Aminoadipic acid,3TMS,isomer #2 | C[Si](C)(C)OC(=O)CCC[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1807.8 | Standard non polar | 33892256 | Aminoadipic acid,3TMS,isomer #2 | C[Si](C)(C)OC(=O)CCC[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 2057.4 | Standard polar | 33892256 | Aminoadipic acid,3TMS,isomer #3 | C[Si](C)(C)OC(=O)[C@H](CCCC(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1861.9 | Semi standard non polar | 33892256 | Aminoadipic acid,3TMS,isomer #3 | C[Si](C)(C)OC(=O)[C@H](CCCC(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1800.2 | Standard non polar | 33892256 | Aminoadipic acid,3TMS,isomer #3 | C[Si](C)(C)OC(=O)[C@H](CCCC(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 2049.0 | Standard polar | 33892256 | Aminoadipic acid,4TMS,isomer #1 | C[Si](C)(C)OC(=O)CCC[C@@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1903.7 | Semi standard non polar | 33892256 | Aminoadipic acid,4TMS,isomer #1 | C[Si](C)(C)OC(=O)CCC[C@@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1865.6 | Standard non polar | 33892256 | Aminoadipic acid,4TMS,isomer #1 | C[Si](C)(C)OC(=O)CCC[C@@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1822.6 | Standard polar | 33892256 | Aminoadipic acid,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CCC[C@H](N)C(=O)O | 1867.3 | Semi standard non polar | 33892256 | Aminoadipic acid,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)[C@@H](N)CCCC(=O)O | 1833.1 | Semi standard non polar | 33892256 | Aminoadipic acid,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N[C@@H](CCCC(=O)O)C(=O)O | 1904.3 | Semi standard non polar | 33892256 | Aminoadipic acid,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CCC[C@H](N)C(=O)O[Si](C)(C)C(C)(C)C | 2076.3 | Semi standard non polar | 33892256 | Aminoadipic acid,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N[C@@H](CCCC(=O)O[Si](C)(C)C(C)(C)C)C(=O)O | 2204.0 | Semi standard non polar | 33892256 | Aminoadipic acid,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N[C@@H](CCCC(=O)O)C(=O)O[Si](C)(C)C(C)(C)C | 2135.3 | Semi standard non polar | 33892256 | Aminoadipic acid,2TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)N([C@@H](CCCC(=O)O)C(=O)O)[Si](C)(C)C(C)(C)C | 2280.7 | Semi standard non polar | 33892256 | Aminoadipic acid,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N[C@@H](CCCC(=O)O[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2381.4 | Semi standard non polar | 33892256 | Aminoadipic acid,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N[C@@H](CCCC(=O)O[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2343.2 | Standard non polar | 33892256 | Aminoadipic acid,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N[C@@H](CCCC(=O)O[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2272.6 | Standard polar | 33892256 | Aminoadipic acid,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)CCC[C@@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2549.6 | Semi standard non polar | 33892256 | Aminoadipic acid,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)CCC[C@@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2399.4 | Standard non polar | 33892256 | Aminoadipic acid,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)CCC[C@@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2342.7 | Standard polar | 33892256 | Aminoadipic acid,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](CCCC(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2526.9 | Semi standard non polar | 33892256 | Aminoadipic acid,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](CCCC(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2370.5 | Standard non polar | 33892256 | Aminoadipic acid,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](CCCC(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2341.2 | Standard polar | 33892256 | Aminoadipic acid,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CCC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2774.1 | Semi standard non polar | 33892256 | Aminoadipic acid,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CCC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2607.9 | Standard non polar | 33892256 | Aminoadipic acid,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)CCC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2313.2 | Standard polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Aminoadipic acid GC-MS (3 TMS) | splash10-02vi-1890000000-cb81ff688a4a1d2ee926 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aminoadipic acid GC-MS (Non-derivatized) - 70eV, Positive | splash10-00xu-9200000000-2a666aa0f9c15fd2295b | 2016-09-22 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aminoadipic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aminoadipic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aminoadipic acid GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aminoadipic acid GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aminoadipic acid GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aminoadipic acid GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aminoadipic acid GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aminoadipic acid GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aminoadipic acid GC-MS (TMS_2_4) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aminoadipic acid GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aminoadipic acid GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aminoadipic acid GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aminoadipic acid GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aminoadipic acid GC-MS (TBDMS_2_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aminoadipic acid GC-MS (TBDMS_2_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aminoadipic acid GC-MS (TBDMS_2_4) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminoadipic acid 10V, Positive-QTOF | splash10-0002-9600000000-77ab58046847c3ea82f0 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminoadipic acid 20V, Positive-QTOF | splash10-0a4j-9000000000-fced5385ac147b0fd6a0 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminoadipic acid 40V, Positive-QTOF | splash10-0a4i-9000000000-3f7c5858ac3e97d89e6e | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminoadipic acid 30V, Positive-QTOF | splash10-0a4i-9000000000-af6e2d829df2d68bd262 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminoadipic acid 40V, Positive-QTOF | splash10-0a4i-9000000000-3664a98748e89e99cd2d | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminoadipic acid 10V, Positive-QTOF | splash10-0002-9700000000-e1040cea3fd3c274b468 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminoadipic acid 20V, Positive-QTOF | splash10-052b-9000000000-c9da617e7f36084d0276 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminoadipic acid 10V, Positive-QTOF | splash10-00kb-9800000000-2738b9d8b78b33fed9f7 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminoadipic acid 35V, Positive-QTOF | splash10-00ke-7900000000-461c76f7d777bbdee97e | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminoadipic acid 40V, Positive-QTOF | splash10-0a4i-9000000000-b096dea8b50a6e2c75c4 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminoadipic acid 10V, Positive-QTOF | splash10-00ke-7900000000-cfb9ae7bd0906a939368 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminoadipic acid 20V, Positive-QTOF | splash10-0a4j-9000000000-7c27445e72a5da0c3bb6 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminoadipic acid 10V, Positive-QTOF | splash10-014j-6900000000-f349746a9f0635231c65 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminoadipic acid 0V, Positive-QTOF | splash10-03di-0900000000-1bc82027155d45c9a43d | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminoadipic acid 30V, Positive-QTOF | splash10-0a4i-9000000000-2749c34e547a235a0f78 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminoadipic acid 0V, Positive-QTOF | splash10-03di-0900000000-97545962897518937c04 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminoadipic acid 30V, Positive-QTOF | splash10-0a4i-9000000000-0e2bf30c88b4dafc0c5f | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminoadipic acid 10V, Positive-QTOF | splash10-0002-9500000000-83d347e56da993118fba | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aminoadipic acid 10V, Negative-QTOF | splash10-03xu-1900000000-db1ee9542c240bfe00b7 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aminoadipic acid 10V, Positive-QTOF | splash10-00kg-2900000000-3e45ac769d3b229221a3 | 2015-09-15 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aminoadipic acid 20V, Positive-QTOF | splash10-01ba-9600000000-c51318834cc371625d46 | 2015-09-15 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aminoadipic acid 40V, Positive-QTOF | splash10-05fu-9000000000-edbc970f12ea186bcf06 | 2015-09-15 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aminoadipic acid 10V, Negative-QTOF | splash10-03di-1900000000-0f7002659f604cc69395 | 2015-09-15 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aminoadipic acid 20V, Negative-QTOF | splash10-01ox-4900000000-bf42ddc971a2a05516a2 | 2015-09-15 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aminoadipic acid 40V, Negative-QTOF | splash10-0abc-9100000000-1979c27463bab7d33d58 | 2015-09-15 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Quadrupole Ion Trap, ESI+, Adduct: [M+H]+) | 2022-02-11 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Quadrupole Ion Trap, ESI+, Adduct: [M+Na]+) | 2022-02-11 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Quadrupole Ion Trap, ESI-, Adduct: [M-H]-) | 2022-02-11 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected and Quantified | 2.0 (0.0-5.0) uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.30-3.40 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 1.14(0.81-9.66) uM | Children (1-13 uears old) | Both | Normal | | details | Blood | Detected and Quantified | 0 uM | Children (1 - 13 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.30-3.40 uM | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Not Specified | Normal | | details | Saliva | Detected and Quantified | 0.804 +/- 1.44 uM | Adult (>18 years old) | Female | Normal | | details | Saliva | Detected and Quantified | 0.821 +/- 0.408 uM | Adult (>18 years old) | Female | Normal | | details | Saliva | Detected and Quantified | 0.952 +/- 1.49 uM | Adult (>18 years old) | Female | Normal | | details | Saliva | Detected and Quantified | 0.336 +/- 0.475 uM | Adult (>18 years old) | Male | Normal | | details | Urine | Detected and Quantified | 20.4023 +/- 11.4518 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Normal | | details | Urine | Detected and Quantified | 15.83 +/- 12.44 umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details | Urine | Detected and Quantified | 19.22 +/- 15.83 umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details | Urine | Detected and Quantified | 24.87 +/- 15.83 umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details | Urine | Detected and Quantified | <9.50 umol/mmol creatinine | Children (1-13 years old) | Not Specified | Normal | | details | Urine | Detected and Quantified | 1.7-4.2 umol/mmol creatinine | Adult (>18 years old) | Female | Normal | | details | Urine | Detected and Quantified | 4.6 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 40.736 +/- 34.234 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 1.23-15.5 umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details | Urine | Detected and Quantified | 8.52 +/- 4.45 umol/mmol creatinine | Newborn (0-30 days old) | Female | Normal | | details | Urine | Detected and Quantified | 6.09 +/- 3.36 umol/mmol creatinine | Newborn (0-30 days old) | Male | Normal | | details | Urine | Detected and Quantified | <8.60 umol/mmol creatinine | Adolescent (13-18 years old) | Not Specified | Normal | | details | Urine | Detected and Quantified | <5.32 umol/mmol creatinine | Adult (>18 years old) | Not Specified | Normal | | details | Urine | Detected and Quantified | 1.9-4.3 umol/mmol creatinine | Adult (>18 years old) | Male | Normal | | details | Urine | Detected and Quantified | 1.13-31.1 umol/mmol creatinine | Infant (0-1 year old) | Not Specified | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.633 +/- 1.0288 umol/mmol creatinine | Not Specified | Not Specified | Normal | | details | Urine | Detected and Quantified | 7.3 (3.4-11.2) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 1.70-36.65 umol/mmol creatinine | Children (1-13 years old) | Not Specified | Normal | | details | Urine | Detected and Quantified | 7.2 (2.5-16.4) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 1.13-15.27 umol/mmol creatinine | Children (1-13 years old) | Not Specified | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Detected and Quantified | 6.0 (7.0-8.0) uM | Adult (>18 years old) | Both | alpha-Aminoadipic aciduria | | details | Blood | Detected and Quantified | 1.07(0.70-3.17) uM | Children (1-13 uears old) | Both | Environmental enteric dysfunction | | details | Blood | Detected and Quantified | 18.7 uM | Children (1-13 years old) | Male | Alpha-aminoadipic and alpha-ketoadipic aciduria | | details | Blood | Detected and Quantified | 48.0 uM | Children (1-13 years old) | Both | alpha-Aminoadipic aciduria | | details | Blood | Detected and Quantified | 55.0 (30.0-80.0) uM | Children (1-13 years old) | Both | 2-Ketoadipic Acidemia | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Metastatic melanoma | | details | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Both | Ulcerative colitis | | details | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Not Specified | Crohns disease | | details | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Not Specified | Ulcerative colitis | | details | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Not Specified | Unclassified IBD | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Urine | Detected and Quantified | 14.3982 +/- 9.7148 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Eosinophilic esophagitis | | details | Urine | Detected and Quantified | 14.0068 +/- 9.2776 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Gastroesophageal reflux disease | | details | Urine | Detected and Quantified | 45.554 +/- 68.592 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Eosinophilic esophagitis | | details | Urine | Detected and Quantified | 148 umol/mmol creatinine | Adolescent (13-18 years old) | Male | alpha-Ketoadipic Aciduria | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Bladder cancer | | details | Urine | Detected and Quantified | 42.612 umol/mmol creatinine | Children (1-13 years old) | Male | Alpha-aminoadipic and alpha-ketoadipic aciduria | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Schizophrenia | | details | Urine | Detected and Quantified | 13000 umol/mmol creatinine | Children (1-13 years old) | Both | alpha-Aminoadipic aciduria | | details | Urine | Detected and Quantified | 240-1910 umol/mmol creatinine | Children (1-13 years old) | Not Specified | alpha-Aminoadipic aciduria | | details | Urine | Detected and Quantified | 1243 umol/mmol creatinine | Infant (0-1 year old) | Not Specified | alpha-ketoadipic aciduria | | details | Urine | Detected and Quantified | 176 umol/mmol creatinine | Newborn (0-30 days old) | Not Specified | alpha-ketoadipic aciduria | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Alpha-aminoadipic aciduria |
---|
- Vallat C, Rivier F, Bellet H, Magnan de Bornier B, Mion H, Echenne B: Treatment with vigabatrin may mimic alpha-aminoadipic aciduria. Epilepsia. 1996 Aug;37(8):803-5. [PubMed:8764822 ]
- Gray RG, O'Neill EM, Pollitt RJ: Alpha-aminoadipic aciduria: chemical and enzymatic studies. J Inherit Metab Dis. 1980;2(4):89-92. [PubMed:6796766 ]
- G.Frauendienst-Egger, Friedrich K. Trefz (2017). MetaGene: Metabolic & Genetic Information Center (MIC: http://www.metagene.de). METAGENE consortium.
| 2-Ketoadipic acidemia |
---|
- Chalmers RA, Lawson AM, Watts RW, Tavill AS, Kamerling JP, Hey E, Ogilvie D: D-2-hydroxyglutaric aciduria: case report and biochemical studies. J Inherit Metab Dis. 1980;3(1):11-5. [PubMed:6774165 ]
- Peng H, Shinka T, Inoue Y, Mitsubuchi H, Ishimatsu J, Yoshino M, Kuhara T: Asymptomatic alpha-ketoadipic aciduria detected during a pilot study of neonatal urine screening. Acta Paediatr. 1999 Aug;88(8):911-4. [PubMed:10503694 ]
- G.Frauendienst-Egger, Friedrich K. Trefz (2017). MetaGene: Metabolic & Genetic Information Center (MIC: http://www.metagene.de). METAGENE consortium.
| Ulcerative colitis |
---|
- Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158. [PubMed:27609529 ]
| Crohn's disease |
---|
- Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158. [PubMed:27609529 ]
| Metastatic melanoma |
---|
- Frankel AE, Coughlin LA, Kim J, Froehlich TW, Xie Y, Frenkel EP, Koh AY: Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients. Neoplasia. 2017 Oct;19(10):848-855. doi: 10.1016/j.neo.2017.08.004. Epub 2017 Sep 15. [PubMed:28923537 ]
| Colorectal cancer |
---|
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
| Eosinophilic esophagitis |
---|
- Slae, M., Huynh, H., Wishart, D.S. (2014). Analysis of 30 normal pediatric urine samples via NMR spectroscopy (unpublished work). NA.
| Schizophrenia |
---|
- Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K, Cao Y, Wang X, Qiu Y, Su M, Zhao A, Wang P, Yang P, Wu J, Feng G, He L, Jia W, Wan C: Potential metabolite markers of schizophrenia. Mol Psychiatry. 2013 Jan;18(1):67-78. doi: 10.1038/mp.2011.131. Epub 2011 Oct 25. [PubMed:22024767 ]
| Alpha-aminoadipic and alpha-ketoadipic aciduria |
---|
- Takechi T, Okada T, Wakiguchi H, Morita H, Kurashige T, Sugahara K, Kodama H: Identification of N-acetyl-alpha-aminoadipic acid in the urine of a patient with alpha-aminoadipic and alpha-ketoadipic aciduria. J Inherit Metab Dis. 1993;16(1):119-26. [PubMed:8487492 ]
|
|
---|
Associated OMIM IDs | |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB021812 |
---|
KNApSAcK ID | C00007393 |
---|
Chemspider ID | 83182 |
---|
KEGG Compound ID | C00956 |
---|
BioCyc ID | CPD-468 |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Alpha-Aminoadipic_acid |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 92136 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 37023 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | L2AADP |
---|
MarkerDB ID | MDB00000178 |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Khan, Naseem H.; Ali, Mohd.; Panda, H.; Rakhshinda. Synthesis of a-aminoadipic acid. Journal of the Indian Chemical Society (1982), 59(9), 1077-8. |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Fiermonte G, Dolce V, Palmieri L, Ventura M, Runswick MJ, Palmieri F, Walker JE: Identification of the human mitochondrial oxodicarboxylate carrier. Bacterial expression, reconstitution, functional characterization, tissue distribution, and chromosomal location. J Biol Chem. 2001 Mar 16;276(11):8225-30. Epub 2000 Nov 16. [PubMed:11083877 ]
- Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM: Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009 Feb 12;457(7231):910-4. doi: 10.1038/nature07762. [PubMed:19212411 ]
- Brauner-Osborne H, Slok FA, Skjaerbaek N, Ebert B, Sekiyama N, Nakanishi S, Krogsgaard-Larsen P: A new highly selective metabotropic excitatory amino acid agonist: 2-amino-4-(3-hydroxy-5-methylisoxazol-4-yl)butyric acid. J Med Chem. 1996 Aug 2;39(16):3188-94. [PubMed:8759641 ]
- Hori S: [Pathophysiology of intraocular neovascularization]. Nippon Ganka Gakkai Zasshi. 1990 Dec;94(12):1103-21. [PubMed:1707214 ]
- Ouwerkerk-Mahadevan S, Mulder GJ: Inhibition of glutathione conjugation in the rat in vivo by analogues of glutathione conjugates. Chem Biol Interact. 1998 Apr 24;111-112:163-76. [PubMed:9679552 ]
- Mechanic GL: The qualitative and quantitative crosslink chemistry of collagen matrices. Adv Exp Med Biol. 1977;86B:699-708. [PubMed:20755 ]
- Okuno E, Tsujimoto M, Nakamura M, Kido R: 2-Aminoadipate-2-oxoglutarate aminotransferase isoenzymes in human liver: a plausible physiological role in lysine and tryptophan metabolism. Enzyme Protein. 1993;47(3):136-48. [PubMed:8087205 ]
- Takechi T, Okada T, Wakiguchi H, Morita H, Kurashige T, Sugahara K, Kodama H: Identification of N-acetyl-alpha-aminoadipic acid in the urine of a patient with alpha-aminoadipic and alpha-ketoadipic aciduria. J Inherit Metab Dis. 1993;16(1):119-26. [PubMed:8487492 ]
- Wu HQ, Ungerstedt U, Schwarcz R: L-alpha-aminoadipic acid as a regulator of kynurenic acid production in the hippocampus: a microdialysis study in freely moving rats. Eur J Pharmacol. 1995 Jul 25;281(1):55-61. [PubMed:8566117 ]
- Jung K, Reszka R, Kamlage B, Bethan B, Stephan C, Lein M, Kristiansen G: Tissue metabolite profiling identifies differentiating and prognostic biomarkers for prostate carcinoma. Int J Cancer. 2013 Dec 15;133(12):2914-24. doi: 10.1002/ijc.28303. Epub 2013 Jun 29. [PubMed:23737455 ]
- Danhauser K, Sauer SW, Haack TB, Wieland T, Staufner C, Graf E, Zschocke J, Strom TM, Traub T, Okun JG, Meitinger T, Hoffmann GF, Prokisch H, Kolker S: DHTKD1 mutations cause 2-aminoadipic and 2-oxoadipic aciduria. Am J Hum Genet. 2012 Dec 7;91(6):1082-7. doi: 10.1016/j.ajhg.2012.10.006. Epub 2012 Nov 8. [PubMed:23141293 ]
- Sell DR, Strauch CM, Shen W, Monnier VM: 2-aminoadipic acid is a marker of protein carbonyl oxidation in the aging human skin: effects of diabetes, renal failure and sepsis. Biochem J. 2007 Jun 1;404(2):269-77. [PubMed:17313367 ]
- Wijekoon EP, Skinner C, Brosnan ME, Brosnan JT: Amino acid metabolism in the Zucker diabetic fatty rat: effects of insulin resistance and of type 2 diabetes. Can J Physiol Pharmacol. 2004 Jul;82(7):506-14. [PubMed:15389298 ]
- Yuan W, Zhang J, Li S, Edwards JL: Amine metabolomics of hyperglycemic endothelial cells using capillary LC-MS with isobaric tagging. J Proteome Res. 2011 Nov 4;10(11):5242-50. doi: 10.1021/pr200815c. Epub 2011 Oct 17. [PubMed:21961526 ]
- Zeitoun-Ghandour S, Leszczyszyn OI, Blindauer CA, Geier FM, Bundy JG, Sturzenbaum SR: C. elegans metallothioneins: response to and defence against ROS toxicity. Mol Biosyst. 2011 Aug;7(8):2397-406. doi: 10.1039/c1mb05114h. Epub 2011 Jun 7. [PubMed:21647514 ]
- Sell DR, Strauch CM, Shen W, Monnier VM: Aging, diabetes, and renal failure catalyze the oxidation of lysyl residues to 2-aminoadipic acid in human skin collagen: evidence for metal-catalyzed oxidation mediated by alpha-dicarbonyls. Ann N Y Acad Sci. 2008 Apr;1126:205-9. doi: 10.1196/annals.1433.065. [PubMed:18448817 ]
- Wang TJ, Ngo D, Psychogios N, Dejam A, Larson MG, Vasan RS, Ghorbani A, O'Sullivan J, Cheng S, Rhee EP, Sinha S, McCabe E, Fox CS, O'Donnell CJ, Ho JE, Florez JC, Magnusson M, Pierce KA, Souza AL, Yu Y, Carter C, Light PE, Melander O, Clish CB, Gerszten RE: 2-Aminoadipic acid is a biomarker for diabetes risk. J Clin Invest. 2013 Oct;123(10):4309-17. doi: 10.1172/JCI64801. Epub 2013 Sep 16. [PubMed:24091325 ]
- Lin H, Levison BS, Buffa JA, Huang Y, Fu X, Wang Z, Gogonea V, DiDonato JA, Hazen SL: Myeloperoxidase-mediated protein lysine oxidation generates 2-aminoadipic acid and lysine nitrile in vivo. Free Radic Biol Med. 2017 Mar;104:20-31. doi: 10.1016/j.freeradbiomed.2017.01.006. Epub 2017 Jan 6. [PubMed:28069522 ]
- Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043. [PubMed:32033212 ]
|
---|